Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H23N3 |
| Molecular Weight | 293.406 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(\C=N\C1=CC=C(C)C=C1C)\C=N\C2=CC=C(C)C=C2C
InChI
InChIKey=QXAITBQSYVNQDR-ZIOPAAQOSA-N
InChI=1S/C19H23N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3/b20-12+,21-13+
| Molecular Formula | C19H23N3 |
| Molecular Weight | 293.406 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Optical Activity | NONE |
DescriptionSources: http://medind.nic.in/ibv/t04/i5/ibvt04i5p482.pdfCurator's Comment: description was created based on several sources, including
http://www.merckvetmanual.com/mvm/pharmacology/ectoparasiticides/ectoparasiticides_used_in_large_animals.html
Sources: http://medind.nic.in/ibv/t04/i5/ibvt04i5p482.pdf
Curator's Comment: description was created based on several sources, including
http://www.merckvetmanual.com/mvm/pharmacology/ectoparasiticides/ectoparasiticides_used_in_large_animals.html
Amitraz (development code BTS27419) is a non-systemic acaricide and insecticide and has also been described as a scabicide. It was first synthesized by the Boots Co. in England in 1969. Amitraz is the only formamidine used as an ectoparasiticide. It appears to act by inhibition of the enzyme monoamine oxidase and as an agonist at octopamine receptors. Monoamine oxidase metabolizes amine neurotransmitters in ticks and mites, and octopamine is thought to modify tonic contractions in parasite muscles. Amitraz has a relatively wide safety margin in mammals; the most frequently associated adverse effect is sedation, which may be associated with an agonist activity of amitraz on α2-receptors in mammalian species. Amitraz is available as a spray or dip for use against mites, lice, and ticks in domestic livestock. It controls lice and mange in pigs and psoroptic mange in sheep. In cattle, it has been used in dips, sprays, or pour-ons for control of single-host and multihost tick species. In dipping baths, amitraz can be stabilized by the addition of calcium hydroxide and maintained by standard replenishment methods for routine tick control. An alternative method involves the use of total replenishment formulations in which the dip bath is replenished with full concentration of amitraz at weekly intervals before use. Amitraz is contraindicated in horses. Amitraz has antipyretic and antiinflammatory activity in vivo, and also has been shown to inhibit prostaglandin E2 synthesis(13). Decreased body temperature was observed in two of our cases. The basic approach to the patient with amitraz poisoning includes initial stabilization, treatment to reduce absorption and measures to improve elimination of the toxin. The medical management is essentially symptomatic and supportive. There is no specific antidote. Despite life-threatening symptomatology, all cases may recover completely. In this study we would like to emphasize that the incidence of poisoning with amitraz is increasing due to its widespread use in veterinary medicine. In order to minimize amitraz poisoning, public education should be given on primary prevention of poisoning and besides, producers should redesign containers as childproof packagers with warning labels
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/21288150
Curator's Comment: CNS depression was the most common clinical sign (76.8%) of amitraz poisoning
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development and validation of an analytical method for total amitraz in fruit and honey with quantification by gas chromatography-mass spectrometry. | 2007-03 |
|
| Field evaluation of a botanical natural product against the pear psylla (Homoptera: Psyllidae). | 2007-02 |
|
| Identification of pesticide transformation products in food by liquid chromatography/time-of-flight mass spectrometry via "fragmentation-degradation" relationships. | 2007-01-01 |
|
| Flawed ethics recommendations of the U.S. EPA's human studies review board. | 2007-01 |
|
| Evaluation of developmental toxicity of amitraz in Sprague-Dawley rats. | 2007-01 |
|
| Neurotoxic and general effects of combined subchronic exposure of rats to insecticides and heavy metals. | 2006-12 |
|
| Electrochemical monitoring of the biodegradation of 2,4-dimethylaniline. | 2006-11-15 |
|
| Elimination of sarcoptic mange due to Sarcoptes scabiei var suis from a 1800-sow farrow-to-finish farm. | 2006-10-28 |
|
| Electrochemical investigation of the effect of pH and solvent on amitraz stability. | 2006-10-18 |
|
| Acute amitraz intoxication: retrospective analysis of 45 cases. | 2006-10 |
|
| Efficacy of several anti-tick treatments to prevent the transmission of Rickettsia conorii under natural conditions. | 2006-10 |
|
| Canine renal cortical necrosis and haemorrhage following ingestion of an Amitraz-formulated insecticide dip. | 2006-09 |
|
| Prevalence and potential risk factors for amitraz resistance in Boophilus microplus ticks in cattle farms in the State of Yucatan, Mexico. | 2006-08-17 |
|
| Demodicosis in nine prairie dogs (Cynomys ludovicianus). | 2006-08 |
|
| [Compatibility of two fungal biocontrol agents conidia with commercial chemical acaricides]. | 2006-07 |
|
| Multimodal approach to treatment for control of fur mites. | 2006-07 |
|
| The use of a pour-on and spray dip containing Amitraz to control ticks (Acari: Ixodidae) on cattle. | 2006-06 |
|
| Suspected drug-induced destructive cholangitis in a young dog. | 2006-06 |
|
| Pesticide exposure: the hormonal function of the female reproductive system disrupted? | 2006-05-31 |
|
| [A case of very serious Sarcoptes mange in alpacas (Lama pacos)]. | 2006-04-15 |
|
| In vitro tests for evaluation of the hatchability of the eggs of Psoroptes mites following exposure to acaricidal compounds. | 2006-03 |
|
| Comparative tick counts on game, cattle and sheep on a working game ranch in Kenya. | 2006-01 |
|
| Update on canine demodicosis. | 2006-01 |
|
| Acute amitraz poisoning in adults: clinical features, laboratory findings, and management. | 2006 |
|
| Determination of acaricide residues in saudi arabian honey and beeswax using solid phase extraction and gas chromatography. | 2006 |
|
| Acaricide efficiency of amitraz/cypermethrin and abamectin pour-on preparations in game. | 2005-12 |
|
| Modification of MTT assay conditions to examine the cytotoxic effects of amitraz on the human lymphoblastoid cell line, WIL2NS. | 2005-12 |
|
| Effects of the insecticide amitraz, an alpha2-adrenergic receptor agonist, on human luteinized granulosa cells. | 2005-11 |
|
| Amitraz: an unusual aetiology of Ogilvie's syndrome. | 2005-09 |
|
| Near-fatal amitraz intoxication: the overlooked pesticide. | 2005-09 |
|
| [Alcoholic extract of lemongrass (Cymbopogon citratus) on the control of Boophilus microplus in cattle]. | 2005-08-26 |
|
| Diagnosis of amitraz resistance in Boophilus microplus in New Caledonia with the modified Larval Packet Test. | 2005-06-30 |
|
| BmiGI: a database of cDNAs expressed in Boophilus microplus, the tropical/southern cattle tick. | 2005-06 |
|
| [Additional information on the article amitraz intoxications in the horse]. | 2005-05-01 |
|
| Comparative acaricide susceptibility and detoxifying enzyme activities in field-collected resistant and susceptible strains of Tetranychus urticae. | 2005-05 |
|
| [In Vitro efficacy of comercial formulations of ixocidides in engorged female of Boophilus microplus collected of dairy cattle at Paraíba Valey in the state of São Paulo]. | 2005-03-21 |
|
| Comparison of in vitro and in vivo ectoparasiticide activity of experimental benzimidazole-carbamate with permethrin and amitraz. | 2005-03 |
|
| Efficacy of a collar impregnated with amitraz and pyriproxyfen for prevention of experimental tick infestations by Rhipicephalus sanguineus, Ixodes ricinus, and Ixodes scapularis in dogs. | 2005-01-15 |
|
| Mode of inheritance of amitraz resistance in a Brazilian strain of the southern cattle tick, Boophilus microplus (Acari: Ixodidae). | 2005 |
|
| The relationship between surface adsorption and the hydrolysis of amitraz in anionic surfactant solutions. | 2005 |
|
| Intravenous amitraz poisoning. | 2005 |
|
| Susceptibility of Amblyomma variegatum ticks to acaricides in Ghana. | 2005 |
|
| Structural characterization, physicochemical properties, suspension stability, and adsorption properties of four solid forms of amitraz. | 2004-12-01 |
|
| What is your diagnosis? Juvenile-onset generalised demodicosis. | 2004-11 |
|
| Effects of amitraz on cytochrome P450-dependent monooxygenases and estrogenic activity in MCF-7 human breast cancer cells and immature female rats. | 2004-11 |
|
| Factors that influence the prevalence of acaricide resistance and tick-borne diseases. | 2004-10-28 |
|
| Development of a method for the detection and confirmation of the alpha-2 agonist amitraz and its major metabolite in horse urine. | 2004-10 |
|
| A comparative analysis of immunorestoration and recovery with conventional and immunotherapeutic protocols in canine generalized demodicosis: a newer insight of immunotherapeutic efficacy of T11TS. | 2004 |
|
| Rapid quantitative assay for acaricidal effects on Sarcoptes scabiei var. suis and Otodectes cynotis. | 2004 |
|
| Octopaminergic agonists for the cockroach neuronal octopamine receptor. | 2003 |
Patents
Sample Use Guides
For Use In Animals Only: topically treated with MITABAN (amitraz) at a rate of 10.6 milliliters (contents of one bottle) per 2 gallons of warm water (250 ppm active drug).
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8723754
The toxicity of the acaricide amitraz and its effect on foot-and-mouth disease virus multiplication were evaluated in IB-RS-2 cells in vitro. Foot-and-mouth disease virus infectivity remained essentially unchanged in cells exposed to amitraz (20 ug/ml) 24 hr prior to virus infection or after the adsorption period. Viral RNA synthesis evaluated through [3H]uridine incorporation in cells treated for 24 hr prior to infection was not affected by amitraz
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:34:28 GMT 2025
by
admin
on
Wed Apr 02 08:34:28 GMT 2025
|
| Record UNII |
33IAH5017S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C737
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
||
|
WHO-VATC |
QP53AD51
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
||
|
CFR |
21 CFR 524.86
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
||
|
EPA PESTICIDE CODE |
106201
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
||
|
WHO-VATC |
QP53AD01
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
PROMERIS DUO
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
amitraz
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
CERTIFECT (AUTHORISED)
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | DOGS | ||
|
C74339
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
100000087403
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
33IAH5017S
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL1365675
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
C014983
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
2665
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
SUB05461MIG
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
1028000
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
m1752
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | Merck Index | ||
|
36324
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
DB11373
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
33089-61-1
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
6939
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
251-375-4
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
17763
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | RxNorm | ||
|
5183
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
DTXSID5023871
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
AMITRAZ
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY | |||
|
324552
Created by
admin on Wed Apr 02 08:34:28 GMT 2025 , Edited by admin on Wed Apr 02 08:34:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|